October 15, 2025, 11:25 am | Read time: 10 minutes
Heart attacks are insidious—not only because of their suddenness but also because they can vary depending on the time of day. The risk of severe cases is apparently significantly higher, especially in the early morning hours. But why is that? A new study from the U.S. has provided deeper insights into the biological processes behind this phenomenon for the first time—and discovered a previously unknown protective mechanism in the heart that is controlled by the circadian rhythm.
When a heart attack occurs can be crucial to how severe it is. Numerous clinical observations suggest that heart attacks in the early morning are more likely to be fatal and cause greater damage to the heart muscle. Studies also support this.1,2 However, the biological reasons for this have been unclear until now. A study published in the journal “Nature” by an international team from the University of Texas investigates this question on a molecular level.3 Based on observations of heart attack patients, the responsible scientists conducted experiments on mice. Although animal studies have limited applicability to humans, the investigation provided interesting clues that a time-of-day-dependent protective mechanism is active in the heart at the cellular level, with surprisingly concrete implications for the therapy and prevention of heart attacks.
Overview
Why Does the Time of Day Play a Role in the Severity of a Heart Attack?
Heart attacks occur not only suddenly but also unevenly throughout the day. The previously mentioned studies had already shown that heart attacks occurring in the early morning hours often have more severe outcomes. But why? The team in the new study investigated this question, focusing on the role of circadian rhythm, or the internal biological clock. The protein BMAL1—also known as a transcription factor—is a central regulator (timekeeper) of this clock and influences numerous body functions throughout the day.
The study’s hypothesis: BMAL1 could—in cooperation with the hypoxia factor HIF2A—help determine how severely the heart muscle is damaged during a heart attack. A hypoxia-induced factor, or HIF, is a type of oxygen sensor. It becomes active when cells are deprived of oxygen. In the case of a heart attack, HIF plays a role because the heart muscle no longer receives enough oxygen.
Study Design and Methods
To understand the role of these proteins, the scientists combined various research approaches and steps:
1. They Examined Human Heart Samples
The researchers used heart muscle samples from 73 patients undergoing planned heart surgery. These samples were taken at different times of the day—some in the morning, others in the afternoon, both before and after the procedure. The researchers then analyzed which genes were active in these samples at what times to find differences throughout the day.
2. Experiments with Special Mice
A large part of the research was conducted with mice. This was done because specific genes can be selectively turned off in mice to test their function. The researchers used mice in which the genes for BMAL1, HIF2A, or another potential protective protein called AREG were specifically knocked out in heart muscle cells (so-called “knockout mice”).
3. Induced Controlled Heart Attacks in Mice
In these mice, the scientists induced a controlled heart attack (by briefly interrupting and then restoring the blood supply, similar to a real heart attack). The key was that this was done at two specific times in the mice’s daily rhythm: once at mouse time ZT8 (equivalent to the afternoon or light phase) and once at mouse time ZT20 (equivalent to the night or dark phase). This allowed them to directly investigate the influence of time of day.
4. Measurement of Damage and Function
After the heart attack, they examined how severely the heart muscle was damaged and how well the heart was still pumping. This was done using various methods such as special staining of heart tissue, measurement of damage markers in the blood, and heart ultrasound (echocardiography).
5. Analysis of Molecular Details
Finally, the scientists used very fine techniques like microscopy to closely examine the cells. They also used methods to detect proteins and measure their amounts, as well as high-performance microscopy to see the exact 3D structure of the involved molecules (such as BMAL1 and HIF2A) and understand how they work together.
The goal of all these steps was to decipher the molecular mechanism that could explain the time-of-day-dependent differences in heart damage after a heart attack.
Also interesting: Cardiac Arrest—These Preliminary Symptoms Should Not Be Ignored
Study Results–Key Findings
Indeed, Different Course of Heart Attacks Depending on the Time of Day
First, the mouse experiments impressively confirmed what clinical observations suggested: Heart attacks occurring at mouse time ZT8 (afternoon) resulted in significantly less heart damage (up to 50 percent less) than those at mouse time ZT20 (night).
BMAL1 and HIF2A Are the Heys
The researchers found that this time-dependent protection is closely linked to the activity of BMAL1 (the timekeeper of the internal clock) and HIF2A (the oxygen sensor).
Protective Mechanism Particularly Active at a Certain Time of Day
In the afternoon (ZT8), a “team” of BMAL1 and HIF2A was particularly active and stable in the hearts of the mice.
Production of the Protective Protein (AREG)
When the BMAL1–HIF2A team is active, it boosts the production of a special protective protein called AREG (Amphiregulin). AREG protects heart muscle cells from dying after oxygen deprivation (during a heart attack).
Proof Through Gene Knockout
When the researchers knocked out the gene for BMAL1 or HIF2A (only in the heart muscle cells) in the mice, the time-dependent protection disappeared. No matter when the heart attack occurred, the damage was always high—just like in untreated mice at night. The same happened when the scientists knocked out the gene for the protective protein AREG. Then, too, there was no longer a time-dependent difference in susceptibility to damage. This clearly showed that these three proteins—BMAL1, HIF2A, and AREG—are part of an important protective mechanism in heart attacks.
The study also showed that BMAL1 stabilizes the oxygen sensor HIF2A, ensuring that HIF2A remains active longer. Together, they bind to specific sites in the DNA to read the AREG gene and produce AREG. The very precise 3D structure of the BMAL1–HIF2A complex on the DNA could even be visualized with special microscopy. This allowed the researchers to observe how the proteins physically interact and can control genes.
Evidence Found in Humans as Well
In human heart samples, the researchers also found differences in the activity of BMAL1 and AREG depending on the time of day the samples were taken. Lab tests with human heart muscle cells also showed that oxygen deprivation only led to strong AREG production when the cells’ internal clock was set to the protective time.
Medication Test
Finally, the scientists tested medications that either increase the activity of BMAL1 (such as Nobiletin) or stabilize HIF2A (such as Vadadustat). These medications could reduce heart damage, but their protective effect was highly dependent on the time of day they were administered. This further underscores the importance of time of day and supports the idea that the researched natural protective mechanism could be specifically enhanced.
Significance of the Results
The study from Texas provides the most precise molecular evidence to date that the time of day has a measurable impact on damage from heart attacks. At the center is the newly discovered BMAL1–HIF2A complex, which regulates the severity of heart muscle injuries depending on the time of day, via the protective protein AREG, which prevents heart muscle cells from dying.
The Results Open Up Several New Perspectives:
Chronotherapy
Medications could be administered in a time-optimized manner in the future, depending on when the protective mechanism is most active.
More Targeted Therapies
The proteins BMAL1, HIF2A, and AREG offer concrete targets for new treatment strategies against ischemic heart diseases.
Timing of Therapy as Part of Diagnostics
In the clinic, it could be considered when a heart attack occured to adjust treatment strategies.
Prevention and Precaution
Chronobiological aspects should be more strongly considered in rehabilitation measures or medication plans. The time-of-day-dependent mechanisms might not be limited to heart attacks. They may also play a role in other diseases with oxygen deprivation or inflammation, such as stroke or lung diseases.
The Connection Between the Internal Clock and Tumor Growth of a Glioblastoma
Why Many People Can’t Keep the Weight off After Losing Weight
Context of the Study and Possible Limitations
The strength of the investigation lies in its methodology. It is state-of-the-art, combining human and animal experimental approaches and supporting its findings through biochemical, functional, and structural analyses. Particularly noteworthy is the deciphering of the 3D structure of the BMAL1–HIF2A–DNA complex, which, for the first time, shows how BMAL1 structurally adapts to interact with HIF2A.
Nevertheless, some limitations should be noted. The study does not yet prove direct causality in humans but shows correlations and plausible mechanisms. The number of patients studied was relatively small, especially in the afternoon group, which limits the statistical significance. Additionally, questions remain, such as whether BMAL1 also interacts with other hypoxia factors like HIF1A or whether other proteins similar in function to BMAL1 (e.g., PER2) are also involved. The transferability to other organs and diseases is also not yet clear. Nonetheless, the study is a significant milestone in molecular cardiology—and a prime example of how chronobiology could find its way into therapy in the future.
Conclusion
Case studies and previous research had shown: A heart attack in the morning is potentially more dangerous than in the afternoon or evening. In this regard, the current study provides a number of remarkable explanations despite its limitations.
It seems that our internal clock actually influences how severely the heart is damaged during a heart attack. The molecular timekeeper BMAL1, which activates the protective protein AREG together with HIF2A, is apparently crucial, but only at the “right” time of day, and this does not seem to be the morning for humans.
The research thus lays the foundation for new, time-optimized therapies for heart attacks and other ischemic diseases. With medications, this natural protection could also be specifically enhanced—provided the time of day is taken into account. With further research, understanding in the field of chronotherapy could continue to grow, soon find its way into practical medicine, and thus revolutionize both the prevention and treatment of heart attacks.